This paper introduces a new method for evaluating national publication activities. This new indicator, thought leadership, captures whether the nation is a thought leader (building on the more recently cited literature for that field) or follower (building on the older cited literature for that field). Publication data for 2003 are used to illustrate which nations tend to build on the more recent discoveries in chemistry and clinical medicine. Implications for national and laboratory policy are discussed.
Introduction
Research evaluation has become a large part of the business of science and technology management. Agents at multiple levels -countries, institutions, and research groups -all monitor their status through the use of bibliometric indicators [1] . High performance with regard to these indicators denotes leadership in a particular field of science. As examples, indicators of current leadership refer to an agent who leads in terms of an activity measure, such as the numbers of papers published, particularly if attention is paid to the most current literature. Indicators of discovery leadership refer to an agent who leads in terms of any of a number of impact measures, which are typically based on citation counts to older literature. A nation with a larger fraction of the highly cited papers in a particular field would be a discovery leader in that field.
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Scientometrics 75 (2008) This paper introduces a third form of leadership, thought leadership, a new, independent indicator that serves as a bridge between current leadership and discovery leadership. Thought leadership is an activity measure that examines whether current papers are building on the more recent discoveries or on the older discoveries in a field. It can be used at multiple levels -countries, institutions, or research groups -to show which agents are quick to follow recent discoveries.
We suggest that thought leadership is an important indicator for science policy. Thought leaders have two characteristics. First, they are committed to participating at the forefront of science rather than on older science. Second, they are willing to shift their emphasis from older ideas to newer ideas when warranted. By contrast, thought followers are far less committed to focusing on new science. We also suggest that different measures of thought leadership can make a distinction between leadership at the national policy level and the laboratory level. We will show how some nations may be thought leaders at the national level but not at the laboratory level. Others may have an opposite pattern.
The balance of the paper is organized as follows. First, we briefly review the literature streams that thought leadership is based on: indicators of current leadership, indicators of discovery leadership, and indicators based on reference age. This is followed by a description of our methodology for measuring thought leadership in different scientific fields. The third section provides an analysis of the thought leadership patterns for ten nations in two scientific areas. The paper concludes with a discussion of the implications of thought leadership as an indicator of national or laboratory strength.
Background

Current leadership
The standards for measuring current leadership are well established. Current leadership is simply a count of current scientific publications. Although simple literature counts do not say anything about quality, they have been found to correlate with funding, and are thus widely used [2] . Tabulations of paper counts can be found in many places, depending upon the question of interest. For example, the National Science Board reports the numbers of articles published by year for over 90 different countries, with additional statistics at regional levels [3: Appendix Table 5 -41]. Country rankings based on paper counts have also been done for a variety of topics [4] and at the level of the research group [5] . Such studies are carried out for patents as well as literature [6] .
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Discovery leadership
As mentioned previously, a discovery leader is an agent that is responsible for the most important discoveries. Depending on the level of analysis, this could be a nation, an institution, or a research group. The standards for measuring discovery leadership are much fuzzier than those for current leadership, simply due to the numbers of different impact indicators that are used. One form of discovery leadership is to look at the most highly cited references in a field. For example, King [7] ranked countries by their fraction of the top 1% highly cited papers published between 1997-2001. Rankings such as this show which nations are responsible for the most recent discoveries across all of science. Such rankings could also be done on a field-by-field basis.
Although King based his rankings on relatively recent publications, other studies look at longer time periods. King also counted publications, total citations, and fraction of top 1% highly cited papers for the earlier time period of 1993-1997. May [8] counted the share of total citations by country for papers published over a 14-year time period, 1981-1994. He also reported country rankings based on a relative citation index (RCI) for 20 different fields in science as defined by ISI. Van Raan [5] calculates various citation-based indicators for 10 and 12-year time periods.
In practice, the majority of studies have been done using data from citation indices. Historically, the Thomson Scientific (TS, formerly ISI) databases have been the primary data source for a variety of reasons, such as the inclusion of citation information and restriction to the dominant peer-reviewed journals (around 9,000) in all fields. Van Raan [9] reviews the suitability of the TS databases for such studies. An alternative source of citation data has recently emerged. Scopus, a citation database introduced by Elsevier, has a larger list of publication sources (approximately 15,000). Recent comparisons of the holdings of these two databases suggests that there is a sizable overlap in the two databases [10, 11] . The differences, however, may be important to rankings. The Scopus database has greater representation of journals from the Far East, and covers more of the literature in computer science, math, physics and chemistry. The ISI database, on the other hand, covers the humanities, which is not covered by Scopus. It remains to be seen whether use of the Scopus database for research evaluation studies will have any effect on rankings at national or institutional levels. A comparison of the ISI and Scopus databases for this use would be a welcome addition to the literature.
Problems with using citation data for evaluation purposes have been well noted in the literature. Citation levels can be artificially inflated due to self citations. Negative citations cannot be automatically differentiated from positive citations, and are thus included in indicators. But there is no evidence that these problems will result in fundamental biases in national or institutional rankings.
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Problems with disciplinary bias are not widely discussed in the literature. Small, Sweeney and Greenlee [12] noted that a high citation threshold (such as the top 1% highly cited papers used by King [7] ) over-represents some disciplines (most notably clinical medicine) and under represents others (such as mathematics). Small explores the possibility of using partial citations to resolve this problem. He reports that this approach fails -it simply shifts disciplinary bias from one disciplinary area to another. Disciplinary bias can be reduced by lowering the threshold [13] , but a lower threshold means that less important discoveries are now being included in the calculation of discovery leadership. There is also no logical reason to suspect that disciplinary bias will have a significant effect on national rankings within discipline. Disciplinary bias may, however, have an effect on overall national rankings. The strong bias towards over-representing clinical medicine means that the nation that leads in clinical medicine discoveries will more likely appear as the overall national discovery leader.
Problems with disciplinary domain are also not widely discussed in the literature. This is a more subtle issue. On the surface, the problem seems to be to decide which disciplinary structure to use. In reality, the disciplinary structure that is selected in these studies reflects parochial institutional concerns. For example, the 7-disciplinary structure in King [7] coincides with the institutional structure within the UK. This is not a surprise since the study was funded by UK institutions. A comparable study funded by the U.S. would probably divide the scientific areas so that they coincided with the institutional structure within the U.S. This is not a criticism of such studies, but is rather a natural outcome of researchers who are interested in providing policy insights for a specific nation's institutions, and the fact that the disciplinary domain of national institutions are idiosyncratic to the nation.
Reference age
We are particularly interested in indicators using reference age that are used to evaluate different agents. Usually, these agents are journals. However, it doesn't matter whether the agent is a journal, a research group, an area of science, an institution or a nation. As long as a set of agents are associated with a set of documents, the ages of the references in these documents can be used to evaluate the agents.
Unfortunately, there is no single standard for measuring reference age in the scientific literature. Price [14] suggested that one focus on the number of references that are in the most recent five years divided by the total number of references. Garfield [15] suggested that one focus on the number of references in the past two years divided by the total possible documents that could have been cited over that same time period.
Simpler methods, such as the mean or median reference age, have also been used to analyze the scientific literature. Egghe [16] discusses the relationship between these different measures of reference age. Specifically, he compares the measure suggested by Price and the mean and median reference ages. He shows that, while there is a generally strong relationship between these measures, the Price Index is not a direct function of mean and median. These measures are not interchangeable.
A related topic used in patent studies is that of "cycle time" or "technology cycle time". Pegels and Thirumurthy [17] show that cycle time is negatively correlated with profitability -that is, shorter cycle times increase firm profitability. Additional studies establish cycle time as a valuable indicator related to progress and innovative activity [18, 19] . Extension of this concept into literature studies would suggest that shorter cycle times, or shorter reference ages, might be correlated with higher performing or more innovative work in the scientific literature.
Additional topics in the literature related to reference age include citation half-life and obsolescence. The history of the half-life concept and the effects of obsolescence are well covered by Egghe and Rousseau [20] . Implicit in most discussions of reference age or cycle time is the assumption that past cycle time is a good predictor for future cycle time at the institution, field, or national level.
Methodology
Our study builds on this literature by examining the mean age of the references in a nation's publications in specific scientific fields. Normalization (i.e., accounting for the age of all references in those specific fields) is accomplished by clustering all highly cited references and generating a map of science. Different regions of the map of science form the basis for different fields, and are thus emergent, rather than institutional, definitions of fields. Mean reference age is calculated for a scientific field and then for each agent (i.e., nation) within that field using the papers that cite the references forming the basis for the field. Following is a more detailed description of this methodology.
The data source used in this study is the TS combined Science Citation (SCIE) and Social Science Citation (SSCI) Indexes for 2003. As mentioned earlier, this has been the database used in almost all major studies of national leadership. We use co-citation analysis as a process for normalizing the statistic for reference age. Co-citation analysis is used to identify clusters of references. A hierarchical structure is created so that one can identify groups of inter-related references at multiple levels of analysis. For example, one could look at one specific area within clinical medicine, or one could look at clinical medicine as a whole. The most highly co-cited references (approximately 800,000 references) were clustered into 776 paradigms using three successive clusterings. These paradigms were further aggregated into eight disciplines, as shown in Figure 1 . Our method is similar to that used by Small [12, 21] in that successive (hierarchical) levels of clustering are used. But our method differs from that used by Small in that there is no thresholding between clusterings, and different layout and
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Scientometrics 75 (2008) clustering algorithms are used. A description of the method and algorithms are provided in prior documents by the authors [13, 22] .
With over 800,000 reference papers grouped into 776 paradigms, we then assigned 760,000 current papers (those indexed in 2003) to the paradigms based on their reference lists. 30% of current papers were assignable to one and only one paradigm because all of their references were in one paradigm. The remaining current papers were each partially assigned to multiple paradigms based on the distribution of their references. Mean reference ages 1 were then determined for each paradigm, and for a nation's publication in a paradigm. Averages were then calculated for each nation (weighted according to the national publication levels in the paradigm). This insures that the overall national statistic reflects the relative emphasis that different nations have in selecting environments (which paradigms to focus on) and thought leadership (whether to focus on the more recent discoveries within that paradigm). All references that were not in the initial set of 800,000 highly cited references were excluded from any calculation of mean reference age. This insures that the mean age calculations only refer to the most important discoveries.
This particular use of mean reference age is based on earlier work done at the Center for Research Planning (CRP). CRP also did co-citation analysis of ISI's citation databases to identify paradigms, referring to them as research communities. One of their performance measures was based on the age of the intellectual base (the set of highly cited references). Those paradigms with a younger intellectual base were viewed as having high vitality -the researchers "quickly incorporate(d) new findings into their efforts to solve problems" [23] . CRP converted the average age statistic to a [0,1] variable where 1 was indicative of a paradigm that was science driven. We are refining this measure for this study by going back to the reference age concept and the original interpretation of this statistic (younger average age means higher vitality), but calculating separate statistics for the references in the paradigm and subset of references in the paradigm belonging to a nation. Figure 2 shows the thought leadership patterns for 16 nations in the 79 paradigms associated with Chemistry. The black squares represent the weighted mean ages of the environment that each nation participates in. Overall, the age of the paradigms in chemistry are five years old (the average reference date is 1998 and the database was composed of articles published in 2003). There is some variation in this statistic, simply because not all nations participate in all of the chemistry paradigms. Different combinations of paradigms produce some small differences in the individual means, yet all means are within 0.2 years of each other. The open circles represent the weighted mean ages of the nation's publications in these paradigms. The gap shows whether a nation is focusing on more recent discoveries within its set of paradigms.
Thought leadership in chemistry and clinical medicine
The overall thought leader in chemistry is Switzerland. Researchers in this nation are publishing articles that build on the more recent discoveries in chemistry paradigms. The overall thought follower among the 16 nations shown is Russia. Note that the average ages of the environments (black squares) for these two nations are quite similar. Figure 2 . Thought leadership in chemistry: mean reference dates and environments by country. Full square: average year of all references (for all paradigms in chemistry that the nation participates in) Empty circle: average year of all references in a nation's current papers (for all paradigms in chemistry that the nation participates in)
Scientometrics 75 (2008)
The differences in the national publication patterns seem to be a reflection of what specific discoveries these two nations are building on. Figure 3 shows the thought leadership patterns for 16 nations in Clinical Medicine. The black squares and open circles are defined as in Figure 2 . Clinical Medicine has younger environments than Chemistry (the average reference date is halfway between 1998 and 1999). Once again, there is some variation in the reference dates for the environments for the various countries due to the different combinations of paradigms in which each nation participates.
China is a most interesting country because the average age of the environment is so much younger, nearly 6 months, than any other nation. This suggests that China is selectively focused on very young areas, and also implies that China is selectively deciding not to participate in older areas of science.
However, selecting the younger paradigms does not necessarily result in thought leadership. China is average relative to its environment (there is little gap between the box and open circle). By contrast, Russia is a thought follower; it selects a reasonably young set of paradigms to work in, but then publishes articles that build on the older discoveries in these areas. The overall thought leader in medical science is Switzerland. The fact that the average age of the environments that Switzerland participates in is older may simply mean that researchers have stayed committed to doing research on older paradigms, and there hasn't been as much shift in national resources toward the newer research areas. But the researchers within Switzerland seem to be focused on recent discoveries regardless of the age of the environment. This seems to suggest a national pattern of behavior that could, and should, be considered a national strength.
National vs. laboratory thought leadership
The examples in Figures 2 and 3 illustrate how the concept of thought leadership can be operationalized. The examples also illustrate a dilemma -it is not clear whether we should look at the absolute age of the references in a nation's papers or the gap between the age of the nation's papers and the environment. The position of China is a good example of this dilemma. On the one hand, one could argue that China is a thought leader, particularly in medicine. China is pursuing those environments where Scientometrics 75 (2008) the science is new and seems to be avoiding those areas where the science is old. But, on the other hand, China is not a thought leader within the areas that is pursues.
This dilemma can be resolved when we consider that thought leadership occurs at different levels within a nation. National policy tends to influence what broad areas of science the nation will participate in, and would show up as differences in the position of environments (the black squares) in Figures 2 and 3 . By contrast, laboratory policy refers to the decisions, within a specific national charter, about what specific discoveries to build upon, and would show up as the gaps. For example, China appears to be a thought leader in medicine at the national policy level. Mostly young areas of science are being funded. But thought leadership is not apparent at the laboratory level. Once these areas are funded, the specific discoveries that are built upon are neither older nor younger than what one would expect from random behavior.
The opposite could be said about Switzerland. Switzerland is not a thought leader at the national level. The nation chooses to participate in a broad set of topics in both chemistry and clinical medicine that, in general, are slightly older than the average for the discipline. But Switzerland is clearly a thought leader at the laboratory level. Once an area of science is targeted, the scientists focus on the most recent discoveries within those paradigms.
Implications
Scientometric indicators should be viewed critically, especially if adoption of the indicator is used to evaluate agents, and the agents attempt to increase their ranking by behavior that is considered counter-productive. Anticipating these dysfunctional behaviors is critical if one is going to evaluate the utility of an indicator.
For example, there may be dysfunctional consequences associated with pursuing a thought leadership strategy at the national policy level. A national thought leadership strategy means increasing funding for hot topics such as nanotechnology and biotechnology. But, given the zero-sum nature of most national funding agencies, it also means reducing the funding levels for topics that are not hot or that are not attracting much attention politically. This may be a popular strategy (it may improve the status of the nation), but it is unclear what the economic consequences of that policy may be. It is unclear whether focusing on hot topics really results in more economic growth than remaining focused on colder topics. It may also be a simple reality that national or international crises (i.e. global warming, AIDS, avian flu, energy) may not have a lot of recent discoveries associated with them.
There appear to be fewer dysfunctional consequences by pursuing a thought leadership strategy at the laboratory level. The types of behaviors that one could anticipate from adopting a thought leadership strategy at the laboratory level might be (a) pushing the scientists to publish more quickly (thereby having younger references when the paper is published) or (b) requiring the scientists to be more aware of, refer to, and possibly build upon the more recent discoveries in their field. Neither of these behaviors seems to be highly dysfunctional.
Summary
Thought leadership focuses on the age of the references in an agent's current publications. An agent is considered a thought leader if it is building on the more recent discoveries in its field. At the national policy level, we suggest that the measure of thought leadership should simply be the age of the scientific environments that the nation wants to pursue. At the laboratory level, where the choice of topic is given, we suggest that the measure should shift to relative age.
